LeMaitre Vascular to Present at Upcoming Investor Conferences
LeMaitre Vascular (Nasdaq:LMAT) is set to participate in four key investor conferences in February and March 2021. David Roberts, President, will present at:
- SVB Leerink's Global Healthcare Conference on February 26, 2021, at 8:40 AM EST
- Barclays Global Healthcare Conference on March 9, 2021, at 1:50 PM EST
- 33rd Annual Roth Conference on March 15, 2021, on demand
- Oppenheimer's Healthcare Conference on March 16, 2021, at 3:10 PM EDT
LeMaitre Vascular specializes in devices and services for peripheral vascular disease, helping over 200 million people globally.
- None.
- None.
Insights
Analyzing...
BURLINGTON, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in four upcoming investor conferences.
David Roberts, President, is scheduled to present at the following virtual conferences:
- SVB Leerink's 10th Annual Global Healthcare Conference on Friday, February 26, 2021, at 8:40 AM EST
- Barclays Global Healthcare Conference on Tuesday, March 9, 2021, at 1:50 PM EST
- 33rd Annual Roth Conference on Monday, March 15, 2021, on demand
- Oppenheimer 31st Annual Healthcare Conference on Tuesday, March 16, 2021, at 3:10 PM EDT
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.